Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension

Benzer Materyaller

• Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension
  Yazar:: Bubb, Kristen J, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Engineering of a red-light–activated human cAMP/cGMP-specific phosphodiesterase
  Yazar:: Gasser, Carlos, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
  Yazar:: Pavlaki, Nikoleta, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation.
  Yazar:: Turko, I V, ve diğerleri
  Baskı/Yayın Bilgisi: (1998)
• Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase.
  Yazar:: Meacci, E, ve diğerleri
  Baskı/Yayın Bilgisi: (1992)